Literature DB >> 23223579

Critical hydrogen bond formation for activation of the angiotensin II type 1 receptor.

Jérôme Cabana1, Brian Holleran, Marie-Ève Beaulieu, Richard Leduc, Emanuel Escher, Gaétan Guillemette, Pierre Lavigne.   

Abstract

G protein-coupled receptors contain selectively important residues that play central roles in the conformational changes that occur during receptor activation. Asparagine 111 (N111(3.35)) is such a residue within the angiotensin II type 1 (AT(1)) receptor. Substitution of N111(3.35) for glycine leads to a constitutively active receptor, whereas substitution for tryptophan leads to an inactivable receptor. Here, we analyzed the AT(1) receptor and two mutants (N111G and N111W) by molecular dynamics simulations, which revealed a novel molecular switch involving the strictly conserved residue D74(2.50). Indeed, D74(2.50) forms a stable hydrogen bond (H-bond) with the residue in position 111(3.35) in the wild-type and the inactivable receptor. However, in the constitutively active mutant N111G-AT(1) receptor, residue D74 is reoriented to form a new H-bond with another strictly conserved residue, N46(1.50). When expressed in HEK293 cells, the mutant N46G-AT(1) receptor was poorly activable, although it retained a high binding affinity. Interestingly, the mutant N46G/N111G-AT(1) receptor was also inactivable. Molecular dynamics simulations also revealed the presence of a cluster of hydrophobic residues from transmembrane domains 2, 3, and 7 that appears to stabilize the inactive form of the receptor. Whereas this hydrophobic cluster and the H-bond between D74(2.50) and W111(3.35) are more stable in the inactivable N111W-AT(1) receptor, the mutant N111W/F77A-AT(1) receptor, designed to weaken the hydrophobic core, showed significant agonist-induced signaling. These results support the potential for the formation of an H-bond between residues D74(2.50) and N46(1.50) in the activation of the AT(1) receptor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23223579      PMCID: PMC3554926          DOI: 10.1074/jbc.M112.395939

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  TM2-TM7 interaction in coupling movement of transmembrane helices to activation of the angiotensin II type-1 receptor.

Authors:  Shin-ichiro Miura; Jingli Zhang; John Boros; Sadashiva S Karnik
Journal:  J Biol Chem       Date:  2002-11-21       Impact factor: 5.157

Review 2.  Structural modelling and dynamics of proteins for insights into drug interactions.

Authors:  Tim Werner; Michael B Morris; Siavoush Dastmalchi; W Bret Church
Journal:  Adv Drug Deliv Rev       Date:  2011-12-01       Impact factor: 15.470

Review 3.  Multiple switches in G protein-coupled receptor activation.

Authors:  Shivani Ahuja; Steven O Smith
Journal:  Trends Pharmacol Sci       Date:  2009-09-03       Impact factor: 14.819

4.  The amino-terminus of angiotensin II contacts several ectodomains of the angiotensin II receptor AT1.

Authors:  Dany Fillion; Guillaume Lemieux; Luta Luse Basambombo; Pierre Lavigne; Gaétan Guillemette; Richard Leduc; Emanuel Escher
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

5.  The conformational change responsible for AT1 receptor activation is dependent upon two juxtaposed asparagine residues on transmembrane helices III and VII.

Authors:  A J Balmforth; A J Lee; P Warburton; D Donnelly; S G Ball
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

6.  The constitutively active N111G-AT1 receptor for angiotensin II maintains a high affinity conformation despite being uncoupled from its cognate G protein Gq/11alpha.

Authors:  Mannix Auger-Messier; Martin Clement; Pascal M Lanctot; Patrice C Leclerc; Richard Leduc; Emanuel Escher; Gaetan Guillemette
Journal:  Endocrinology       Date:  2003-08-13       Impact factor: 4.736

7.  Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.

Authors:  Supriyo Bhattacharya; Spencer E Hall; Hubert Li; Nagarajan Vaidehi
Journal:  Biophys J       Date:  2007-12-07       Impact factor: 4.033

8.  Activation of the angiotensin II type 1 receptor leads to movement of the sixth transmembrane domain: analysis by the substituted cysteine accessibility method.

Authors:  Stéphane S Martin; Brian J Holleran; Emanuel Escher; Gaétan Guillemette; Richard Leduc
Journal:  Mol Pharmacol       Date:  2007-04-19       Impact factor: 4.436

9.  Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.

Authors:  Guillaume Lebon; Tony Warne; Patricia C Edwards; Kirstie Bennett; Christopher J Langmead; Andrew G W Leslie; Christopher G Tate
Journal:  Nature       Date:  2011-05-18       Impact factor: 49.962

10.  Crystal structures of a stabilized β1-adrenoceptor bound to the biased agonists bucindolol and carvedilol.

Authors:  Tony Warne; Patricia C Edwards; Andrew G W Leslie; Christopher G Tate
Journal:  Structure       Date:  2012-05-09       Impact factor: 5.006

View more
  9 in total

1.  Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.

Authors:  Jérôme Cabana; Brian Holleran; Richard Leduc; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne
Journal:  J Biol Chem       Date:  2015-05-01       Impact factor: 5.157

2.  The non-biphenyl-tetrazole angiotensin AT1 receptor antagonist eprosartan is a unique and robust inverse agonist of the active state of the AT1 receptor.

Authors:  Takanobu Takezako; Hamiyet Unal; Sadashiva S Karnik; Koichi Node
Journal:  Br J Pharmacol       Date:  2018-05-06       Impact factor: 8.739

3.  Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody.

Authors:  Laura M Wingler; Conor McMahon; Dean P Staus; Robert J Lefkowitz; Andrew C Kruse
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

4.  Structure-Function Basis of Attenuated Inverse Agonism of Angiotensin II Type 1 Receptor Blockers for Active-State Angiotensin II Type 1 Receptor.

Authors:  Takanobu Takezako; Hamiyet Unal; Sadashiva S Karnik; Koichi Node
Journal:  Mol Pharmacol       Date:  2015-06-29       Impact factor: 4.436

5.  Differential light-induced responses in sectorial inherited retinal degeneration.

Authors:  Eva Ramon; Arnau Cordomí; Mònica Aguilà; Sundaramoorthy Srinivasan; Xiaoyun Dong; Anthony T Moore; Andrew R Webster; Michael E Cheetham; Pere Garriga
Journal:  J Biol Chem       Date:  2014-10-30       Impact factor: 5.157

Review 6.  Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism.

Authors:  Takanobu Takezako; Hamiyet Unal; Sadashiva S Karnik; Koichi Node
Journal:  Pharmacol Res       Date:  2017-06-23       Impact factor: 7.658

7.  Structural Elements Directing G Proteins and β-Arrestin Interactions with the Human Melatonin Type 2 Receptor Revealed by Natural Variants.

Authors:  Bianca Plouffe; Angeliki Karamitri; Tilman Flock; Jonathan M Gallion; Shane Houston; Carole A Daly; Amélie Bonnefond; Jean-Luc Guillaume; Christian Le Gouill; Phillipe Froguel; Olivier Lichtarge; Xavier Deupi; Ralf Jockers; Michel Bouvier
Journal:  ACS Pharmacol Transl Sci       Date:  2022-01-25

8.  Mechanism of Hormone Peptide Activation of a GPCR: Angiotensin II Activated State of AT1R Initiated by van der Waals Attraction.

Authors:  Khuraijam Dhanachandra Singh; Hamiyet Unal; Russell Desnoyer; Sadashiva S Karnik
Journal:  J Chem Inf Model       Date:  2019-01-16       Impact factor: 4.956

9.  A coarse-grained elastic network atom contact model and its use in the simulation of protein dynamics and the prediction of the effect of mutations.

Authors:  Vincent Frappier; Rafael J Najmanovich
Journal:  PLoS Comput Biol       Date:  2014-04-24       Impact factor: 4.475

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.